Skip to main content
Erschienen in: Cancer Causes & Control 5/2012

01.05.2012 | Original paper

Coffee, tea, soda, and caffeine intake in relation to risk of adult glioma in the NIH-AARP Diet and Health Study

verfasst von: Robert Dubrow, Amy S. Darefsky, Neal D. Freedman, Albert R. Hollenbeck, Rashmi Sinha

Erschienen in: Cancer Causes & Control | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We utilized the large, prospective NIH-AARP Diet and Health Study to further explore the hypothesis, suggested by two recent prospective cohort studies, that increased intake of coffee, tea, soda, and/or caffeine is associated with reduced adult glioma risk.

Methods

At baseline in 1995–1996, dietary intake, including coffee, tea, and soda, was assessed with a food frequency questionnaire. We used Cox proportional hazards models to calculate adjusted hazard ratios (HR) and 95 % confidence intervals (CI) for glioma risk in relation to beverage intake.

Results

During follow-up of 545,771 participants through 2006, 904 participants were diagnosed with glioma. We found no trends of decreasing glioma risk with increasing intake of specific beverages or total caffeine. HR patterns for consumption of the caffeinated versus decaffeinated form of each beverage were inconsistent with a specific caffeine effect. HR patterns of reduced glioma risk for most categories of beverage intake greater than “none” prompted a post hoc analysis that revealed borderline-significant inverse associations for any versus no intake of tea (HR = 0.84; 95 % CI, 0.69–1.03), total coffee plus tea (HR = 0.70; 95 % CI, 0.48–1.03), and soda (HR = 0.82; 95 % CI, 0.67–1.01).

Conclusions

The borderline-significant inverse associations could be explained by a threshold effect in which any beverage intake above a low level confers a beneficial effect, most likely due to beverage constituents other than caffeine. They could also be explained by non-drinkers of these beverages sharing unknown extraneous characteristics associated with increased glioma risk, or by chance.
Literatur
1.
Zurück zum Zitat Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA (2008) Brain tumor epidemiology consortium. Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113(7 Suppl):1953–1968PubMedCrossRef Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA (2008) Brain tumor epidemiology consortium. Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113(7 Suppl):1953–1968PubMedCrossRef
2.
Zurück zum Zitat Holick CN, Smith SG, Giovannucci E, Michaud DS (2010) Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol Biomarkers Prev 19:39–47PubMedCrossRef Holick CN, Smith SG, Giovannucci E, Michaud DS (2010) Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol Biomarkers Prev 19:39–47PubMedCrossRef
3.
Zurück zum Zitat Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, Dahm CC, Teucher B, Lukanova A, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Kyrozis A, Sacerdote C, Krogh V, Masala G, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Skeie G, Engeset D, Parr CL, Ardanaz E, Chirlaque MD, Dorronsoro M, Sánchez MJ, Argüelles M, Jakszyn P, Nilsson LM, Melin BS, Manjer J, Wirfält E, Khaw KT, Wareham N, Allen NE, Key TJ, Romieu I, Vineis P, Riboli E (2010) Coffee and tea intake and risk of brain tumors in the European prospective investigation into cancer and nutrition (EPIC) cohort study. Am J Clin Nutr 92:1145–1150PubMedCrossRef Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, Dahm CC, Teucher B, Lukanova A, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Kyrozis A, Sacerdote C, Krogh V, Masala G, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Skeie G, Engeset D, Parr CL, Ardanaz E, Chirlaque MD, Dorronsoro M, Sánchez MJ, Argüelles M, Jakszyn P, Nilsson LM, Melin BS, Manjer J, Wirfält E, Khaw KT, Wareham N, Allen NE, Key TJ, Romieu I, Vineis P, Riboli E (2010) Coffee and tea intake and risk of brain tumors in the European prospective investigation into cancer and nutrition (EPIC) cohort study. Am J Clin Nutr 92:1145–1150PubMedCrossRef
4.
Zurück zum Zitat Nkondjock A (2009) Coffee consumption and the risk of cancer: an overview. Cancer Lett 277:121–125PubMedCrossRef Nkondjock A (2009) Coffee consumption and the risk of cancer: an overview. Cancer Lett 277:121–125PubMedCrossRef
5.
Zurück zum Zitat Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439PubMedCrossRef Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439PubMedCrossRef
6.
Zurück zum Zitat Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40:1155–1163PubMedCrossRef Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40:1155–1163PubMedCrossRef
7.
Zurück zum Zitat Bode AM, Dong Z (2007) The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 247:26–39PubMedCrossRef Bode AM, Dong Z (2007) The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 247:26–39PubMedCrossRef
8.
Zurück zum Zitat Kang SS, Han KS, Ku BM, Lee YK, Hong J, Shin HY, Almonte AG, Woo DH, Brat DJ, Hwang EM, Yoo SH, Chung CK, Park SH, Paek SH, Roh EJ, Lee SJ, Park JY, Traynelis SF, Lee CJ (2010) Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res 70:1173–1183PubMedCrossRef Kang SS, Han KS, Ku BM, Lee YK, Hong J, Shin HY, Almonte AG, Woo DH, Brat DJ, Hwang EM, Yoo SH, Chung CK, Park SH, Paek SH, Roh EJ, Lee SJ, Park JY, Traynelis SF, Lee CJ (2010) Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res 70:1173–1183PubMedCrossRef
9.
Zurück zum Zitat Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of retired persons diet and health study. Am J Epidemiol 154:1119–1125PubMedCrossRef Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of retired persons diet and health study. Am J Epidemiol 154:1119–1125PubMedCrossRef
10.
Zurück zum Zitat Park Y, Mitrou PN, Kipnis V, Hollenbeck A, Schatzkin A, Leitzmann MF (2007) Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 166:1270–1279PubMedCrossRef Park Y, Mitrou PN, Kipnis V, Hollenbeck A, Schatzkin A, Leitzmann MF (2007) Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 166:1270–1279PubMedCrossRef
11.
Zurück zum Zitat Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manag 32:70–75 Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manag 32:70–75
12.
Zurück zum Zitat Schreiber GB, Maffeo CE, Robins M, Masters MN, Bond AP (1988) Measurement of coffee and caffeine intake: implications for epidemiologic research. Prev Med 17:280–294PubMedCrossRef Schreiber GB, Maffeo CE, Robins M, Masters MN, Bond AP (1988) Measurement of coffee and caffeine intake: implications for epidemiologic research. Prev Med 17:280–294PubMedCrossRef
13.
14.
Zurück zum Zitat Sachinidis A, Seul C, Seewald S, Ahn H, Ko Y, Vetter H (2000) Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett 471:51–55PubMedCrossRef Sachinidis A, Seul C, Seewald S, Ahn H, Ko Y, Vetter H (2000) Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett 471:51–55PubMedCrossRef
15.
Zurück zum Zitat Pérez-Martínez M, Caemmerer B, De Peña MP, Cid C, Kroh LW (2010) Influence of brewing method and acidity regulators on the antioxidant capacity of coffee brews. J Agric Food Chem 58:2958–2965PubMedCrossRef Pérez-Martínez M, Caemmerer B, De Peña MP, Cid C, Kroh LW (2010) Influence of brewing method and acidity regulators on the antioxidant capacity of coffee brews. J Agric Food Chem 58:2958–2965PubMedCrossRef
16.
Zurück zum Zitat Urgert R, van der Weg G, Kosmeijer-Schuil TG, van de Bovenkamp P, Hovenier R, Katan MB (1995) Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 43:2167–2172CrossRef Urgert R, van der Weg G, Kosmeijer-Schuil TG, van de Bovenkamp P, Hovenier R, Katan MB (1995) Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 43:2167–2172CrossRef
17.
Zurück zum Zitat Moore SC, Rajaraman P, Dubrow R, Darefsky AS, Koebnick C, Hollenbeck A, Schatzkin A, Leitzmann MF (2009) Height, body mass index, and physical activity in relation to glioma risk. Cancer Res 69:8349–8355PubMedCrossRef Moore SC, Rajaraman P, Dubrow R, Darefsky AS, Koebnick C, Hollenbeck A, Schatzkin A, Leitzmann MF (2009) Height, body mass index, and physical activity in relation to glioma risk. Cancer Res 69:8349–8355PubMedCrossRef
18.
Zurück zum Zitat Dubrow R, Darefsky AS, Park Y, Mayne ST, Moore SC, Kilfoy B, Cross AJ, Sinha R, Hollenbeck AR, Schatzkin A, Ward MH (2010) Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol Biomarkers Prev 19:1709–1722PubMedCrossRef Dubrow R, Darefsky AS, Park Y, Mayne ST, Moore SC, Kilfoy B, Cross AJ, Sinha R, Hollenbeck AR, Schatzkin A, Ward MH (2010) Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol Biomarkers Prev 19:1709–1722PubMedCrossRef
19.
Zurück zum Zitat Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, OxfordCrossRef Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, OxfordCrossRef
20.
Zurück zum Zitat Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B (2010) Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21:1533–1544PubMedCrossRef Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B (2010) Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21:1533–1544PubMedCrossRef
21.
Zurück zum Zitat Efird JT, Friedman GD, Sidney S, klatsky A, Habel LA, Udaltsova NV, Van den Eeden S, Nelson LM (2004) The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol 68:57–69PubMedCrossRef Efird JT, Friedman GD, Sidney S, klatsky A, Habel LA, Udaltsova NV, Van den Eeden S, Nelson LM (2004) The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol 68:57–69PubMedCrossRef
22.
Zurück zum Zitat Burch JD, Craib KJ, Choi BC, Miller AB, Risch HA, Howe GR (1987) An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 78:601–609PubMed Burch JD, Craib KJ, Choi BC, Miller AB, Risch HA, Howe GR (1987) An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 78:601–609PubMed
23.
Zurück zum Zitat Hochberg F, Toniolo P, Cole P, Salcman M (1990) Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 8:55–60PubMedCrossRef Hochberg F, Toniolo P, Cole P, Salcman M (1990) Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 8:55–60PubMedCrossRef
24.
Zurück zum Zitat Blowers L, Preston-Martin S, Mack WJ (1997) Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control 8:5–12PubMedCrossRef Blowers L, Preston-Martin S, Mack WJ (1997) Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control 8:5–12PubMedCrossRef
25.
Zurück zum Zitat Giles GG, McNeil JJ, Donnan G, Webley C, Staples MP, Ireland PD, Hurley SF, Salzberg M (1994) Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer 59:357–362PubMedCrossRef Giles GG, McNeil JJ, Donnan G, Webley C, Staples MP, Ireland PD, Hurley SF, Salzberg M (1994) Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer 59:357–362PubMedCrossRef
26.
Zurück zum Zitat Lee M, Wrensch M, Miike R (1997) Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 8:13–24PubMedCrossRef Lee M, Wrensch M, Miike R (1997) Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 8:13–24PubMedCrossRef
27.
Zurück zum Zitat Schatzkin A, Kipnis V (2004) Could exposure assessment problems give us wrong answers to nutrition and cancer questions? J Natl Cancer Inst 96:1564–1565PubMedCrossRef Schatzkin A, Kipnis V (2004) Could exposure assessment problems give us wrong answers to nutrition and cancer questions? J Natl Cancer Inst 96:1564–1565PubMedCrossRef
Metadaten
Titel
Coffee, tea, soda, and caffeine intake in relation to risk of adult glioma in the NIH-AARP Diet and Health Study
verfasst von
Robert Dubrow
Amy S. Darefsky
Neal D. Freedman
Albert R. Hollenbeck
Rashmi Sinha
Publikationsdatum
01.05.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 5/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9945-6

Weitere Artikel der Ausgabe 5/2012

Cancer Causes & Control 5/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.